NO995966D0 - 5-Naphthalen-1-yl-1,3-dioxane derivatives, their preparation and therapeutic use - Google Patents

5-Naphthalen-1-yl-1,3-dioxane derivatives, their preparation and therapeutic use

Info

Publication number
NO995966D0
NO995966D0 NO995966A NO995966A NO995966D0 NO 995966 D0 NO995966 D0 NO 995966D0 NO 995966 A NO995966 A NO 995966A NO 995966 A NO995966 A NO 995966A NO 995966 D0 NO995966 D0 NO 995966D0
Authority
NO
Norway
Prior art keywords
naphthalen
preparation
therapeutic use
dioxane derivatives
dioxane
Prior art date
Application number
NO995966A
Other languages
Norwegian (no)
Other versions
NO995966L (en
Inventor
Gihad Dargazanli
Patrick Lardenois
Jonathan Frost
Pascal George
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9706944A external-priority patent/FR2764287B1/en
Priority claimed from FR9706947A external-priority patent/FR2764291B1/en
Priority claimed from FR9706946A external-priority patent/FR2764289B1/en
Priority claimed from FR9706945A external-priority patent/FR2764288B1/en
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of NO995966D0 publication Critical patent/NO995966D0/en
Publication of NO995966L publication Critical patent/NO995966L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
NO995966A 1997-06-05 1999-12-03 5-Naphthalen-1-yl-1,3-dioxane derivatives, their preparation and therapeutic use NO995966L (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR9706944A FR2764287B1 (en) 1997-06-05 1997-06-05 5-NAPHTALEN-1-YL-1,3-DIOXANES DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR9706947A FR2764291B1 (en) 1997-06-05 1997-06-05 5-NAPHTALEN-1-YL-1,3-DIOXANE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR9706946A FR2764289B1 (en) 1997-06-05 1997-06-05 5-NAPHTALEN-1-YL-1,3-DIOXANE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR9706945A FR2764288B1 (en) 1997-06-05 1997-06-05 5-NAPHTALEN-1-YL-1,3-DIOXANE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
PCT/FR1998/001113 WO1998055474A1 (en) 1997-06-05 1998-06-03 5-naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutic application

Publications (2)

Publication Number Publication Date
NO995966D0 true NO995966D0 (en) 1999-12-03
NO995966L NO995966L (en) 2000-02-04

Family

ID=27447000

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995966A NO995966L (en) 1997-06-05 1999-12-03 5-Naphthalen-1-yl-1,3-dioxane derivatives, their preparation and therapeutic use

Country Status (18)

Country Link
EP (1) EP0986552A1 (en)
JP (1) JP2002502412A (en)
KR (1) KR20010013435A (en)
CN (1) CN1265658A (en)
AR (1) AR012908A1 (en)
AU (1) AU8025198A (en)
BG (1) BG103937A (en)
BR (1) BR9810742A (en)
CA (1) CA2290695A1 (en)
CO (1) CO4940480A1 (en)
EE (1) EE9900560A (en)
HU (1) HUP0002166A3 (en)
IL (1) IL133242A0 (en)
NO (1) NO995966L (en)
PL (1) PL337234A1 (en)
SK (1) SK166199A3 (en)
TR (1) TR199903022T2 (en)
WO (1) WO1998055474A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA005648B1 (en) * 2000-07-21 2005-04-28 Орто-Макнейл Фармасьютикал, Инк. Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
FR2843964B1 (en) * 2002-08-29 2004-10-01 Sanofi Synthelabo DIOXANE-2-ALKYLCARBAMATES DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE111460T1 (en) * 1990-06-15 1994-09-15 Synthelabo 2-(AMINOALKYL)-5-(ARYLALKYL)1,3-DIOXANE DERIVATIVES, THEIR PRODUCTION AND APPLICATIONS IN THERAPEUTICS.
FR2714055B1 (en) * 1993-12-22 1996-01-19 Synthelabo Derivatives of 5- (arylalkyl) -1,3-dioxane substituted in position 2, their preparation and their use in therapy.
FR2742152B1 (en) * 1995-12-06 1998-01-16 Synthelabo 5-NAPHTALEN-1-YL-1,3-DIOXANES DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

Also Published As

Publication number Publication date
AU8025198A (en) 1998-12-21
BG103937A (en) 2000-07-31
CA2290695A1 (en) 1998-12-10
SK166199A3 (en) 2000-06-12
HUP0002166A2 (en) 2001-06-28
AR012908A1 (en) 2000-11-22
TR199903022T2 (en) 2000-04-21
EE9900560A (en) 2000-06-15
EP0986552A1 (en) 2000-03-22
IL133242A0 (en) 2001-03-19
CN1265658A (en) 2000-09-06
CO4940480A1 (en) 2000-07-24
KR20010013435A (en) 2001-02-26
PL337234A1 (en) 2000-08-14
BR9810742A (en) 2000-09-12
NO995966L (en) 2000-02-04
WO1998055474A1 (en) 1998-12-10
HUP0002166A3 (en) 2002-12-28
JP2002502412A (en) 2002-01-22

Similar Documents

Publication Publication Date Title
DK0869126T3 (en) Dithioland derivatives, their preparation and their therapeutic effect
NO980720D0 (en) Pyridazine-3-one derivatives, their use and intermediates for their preparation
NO954369L (en) Oxazolidinedione derivatives, their preparation and use
IS2277B (en) Therapeutic baryl derivatives
NO985977D0 (en) Spiro-piperidine derivatives and their use as therapeutic agents
DK1161434T3 (en) Pyridopyranoazepine derivatives, their preparation and therapeutic use
NO943682D0 (en) Imidazol-4-yl-piperidine derivatives, their preparation and therapeutic use
NO20023146L (en) Substituted phenyl-piperazine derivatives, their preparation and use
NO20003773D0 (en) Cyclobutene derivatives, their preparation and their therapeutic uses
DK1043307T3 (en) 3-Amino-3-arylpropan-1-ol derivatives, their preparation and use
NO992676D0 (en) 1,4-Diazabicyclo [2,2,2] oct-2-ylmethyl derivatives, their preparation and therapeutic use
NO962477L (en) Benzamide derivatives, their preparation and their therapeutic use
DK0835254T3 (en) Oxazolidinone derivatives, their preparation and their therapeutic use
NO955242D0 (en) Piperidine derivatives, processes for their preparation and their therapeutic use
NO20000066D0 (en) 6-Pyrrolidin-2-ylpyrindine Derivatives, their Preparation and their Pharmaceutical Use
NO982549D0 (en) 5-Naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutic use thereof
NO20012802D0 (en) Benzofuran derivatives, their preparation and use
NO995966D0 (en) 5-Naphthalen-1-yl-1,3-dioxane derivatives, their preparation and therapeutic use
NO20001782D0 (en) 3-Amino-3-arylpropan-1-ol derivatives, their preparation and use
NO950560L (en) Piperazine derivatives, their preparation and therapeutic use
NO996156L (en) Substituted cycloheptans, their preparation and use
NO992436D0 (en) N (imidazolylbutyl) benzenesulfonamide derivatives, their preparation and therapeutic use
NO951812D0 (en) Pyrrole derivatives, their preparation and use
NO20023003L (en) Benzophenone glycopyranosides, as well as preparation and therapeutic use
NO20022482L (en) 2-arylquinoline derivatives, method and therapeutic use thereof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application